An interventional study of Questionnaire and Physical measurements in Non Communicable Diseases, Microbiome and Communicable Diseases, sponsored by Institut Louis Malardé. Completed at 1 site in French Polynesia. Open to participants aged 18 Years to 69 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-18.
Sponsored by Institut Louis Malardé · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This is a cross-sectional study carried out on a sample of the adult population aged 18 to 69, distributed over the five archipelagos of French Polynesia.
Participation in the study involves: agreement to answer a questionnaire to collect information on socio-demographic characteristics, lifestyle habits and medical history; physical measurements (height, weight, waist circumference, blood pressure and skin pigmentation); and agreement to take biological samples (blood, saliva and stool) for biological, genetic and microbiological analyses.
The aim of the study is to assess the current health status of the population of French Polynesia and to evaluate the influence of contextual risk factors (lifestyle, place of residence, history of infection) and intrinsic susceptibility factors (genetics, age, gender, microbiota) in relation to non-communicable and infectious diseases.
146 studies on the registry are indexed under Noncommunicable Diseases; 57 are open to participants now.
This study's enrollment of 1,942 is above the median of 478 across 97 interventional studies indexed under Noncommunicable Diseases.
Browse Noncommunicable Diseases studies →This is the only study on the registry with Institut Louis Malardé as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Population sample composed of people aged 18 to 69. These people must have been living in French Polynesia for more than two years at the time of the 2017 census
Other: Questionnaire · Other: Physical measurements · Other: Biological samples
Questionnaire about socio-demographical status, health status and lifestyle habits
Measurement of height, weight, waist circumference, blood pressure and skin pigmentation
Collect venous blood, saliva and stool samples
Prevalence of obesity
Proportion of participants with indicators of obesity based on physical measurements (BMI, waist circumference) and quantification of lipid levels from blood samples.
Time frame: 2 years
Prevalence of diabetes
Proportion of participants with indicators of diabetes based on self-reported data on diabetes history (previous diagnosis, antidiabetic treatment) and quantification of glycated haemoglobin from blood samples.
Time frame: 2 years
Prevalence of cardiovascular diseases
Proportion of participants with indicators of cardiovascular diseases based on self-reported data on history of hypertension (previous diagnosis, treatment for hypertension), blood pressure measurement, and quantification of lipid levels from blood samples.
Time frame: 2 years
Association between non-communicable diseases and behavioral factors
Calculation of odd ratios to investigate association between non-communicable diseases (obesity, diabetes, cardiovascular diseases) and behavioral factors such as tobacco smoking, alcohol consumption, diet or physical activity data self-reported by the participants in the questionnaire.
Time frame: 2 years
Association between non-communicable diseases and physical measurements
Calculation of odd ratios to investigate association between non-communicable diseases (obesity, diabetes, cardiovascular diseases) and physical measurements such as BMI (based on the BMI formula i.e., weight in kilograms divided by height in meters squared).
Time frame: 2 years
Association between non-communicable diseases and blood analyses
Calculation of odd ratios to investigate association between non-communicable diseases (obesity, diabetes, cardiovascular diseases) and blood analyses (such as glycated haemoglobin and lipid levels).
Time frame: 2 years
Seroprevalence of communicable diseases
Proportion of participants with IgG antibodies, detected in blood samples, specific for different pathogens : arboviruses (four dengue serotypes, Zika, chikungunya), hepatitis B and C viruses, hantaviruses, SARS-CoV-2 and other pathogens known to regularly cause infections in French Polynesia (including influenza viruses, human immunodeficiency virus...). Proportion of participants with positive filarial antigenemia to assess the prevalence of Bancroftian lymphatic filariasis.
Time frame: 2 years
Composition of microbiome
Bacterial DNA sequencing from stool and saliva samples to assess the gut and oral microbiota profiles and association with lifestyle behavior, diet and susceptibility to communicable and non-communicable diseases.
Time frame: 2 years
Level of exposure to heavy metals
Quantification of levels of heavy metals (including mercury and lead) from blood samples and association with lifestyle behavior and diet.
Time frame: 2 years
Level of exposure to pesticides
Quantification of levels of pesticides (including chlordane and toxaphene) from blood samples and association with lifestyle behavior and diet.
Time frame: 2 years
Level of exposure to mosquito bites
Proportion of participants with IgG antibodies targeting mosquito salivary proteins in blood samples to assess the risk of infection by mosquito-borne viruses
Time frame: 2 years
Prevalence of ciguatera poisoning
Estimation of the rate of ciguatera poisoning in the population based on data self-reported by the participants in the questionnaire e.g. the occurrence of symptoms suggestive for ciguatera poisoning at least once in their lifetime
Time frame: 2 years
Demographic and adaptive history of French Polynesians using genomics
Human Whole Genome Sequencing from saliva samples to reconstruct the genetic history of the population of French Polynesia, in terms of both demographic and adaptive history.
Time frame: 2 years
Genetic susceptibility to obesity
Genome-wide association studies to identify human genetic factors that are associated with BMI or lipids levels.
Time frame: 2 years
Genetic susceptibility to diabetes
Genome-wide association studies to identify human genetic factors that are associated with HbA1c.
Time frame: 2 years
Genetic susceptibility to communicable diseases
Genome-wide association studies to identify human genetic factors that are associated with the detection of IgG antibodies specific for different pathogens: arboviruses, hepatitis B and C viruses, hantaviruses, SARS-CoV-2 and other pathogens known to regularly cause infections in French Polynesia (including influenza viruses, human immunodeficiency virus...).
Time frame: 2 years
Ran from Nov 2019 to primary completion in Dec 2021, 25 months.
Of 79 non-industry interventional studies with no phase under Noncommunicable Diseases, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's 25 months is above that.
Counting every sponsor, half of 79 studies reached it within 17 months; a quarter within 7 and three quarters within 30.
Noncommunicable Diseases covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.